{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:49:11Z","timestamp":1790668151810,"version":"4.1.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T00:00:00Z","timestamp":1552348800000},"content-version":"vor","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["U01 HG007269"],"award-info":[{"award-number":["U01 HG007269"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015854","name":"Scott R. MacKenzie Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR000064"],"award-info":[{"award-number":["UL1 TR000064"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007560","name":"Chiesi Farmaceutici","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.jcin.2017.10.051","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T14:08:11Z","timestamp":1520258891000},"page":"417-434","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["A Multidisciplinary Approach on the\u00a0Perioperative Antithrombotic Management\u00a0of Patients With Coronary\u00a0Stents Undergoing Surgery"],"prefix":"10.1016","volume":"11","author":[{"given":"Roberta","family":"Rossini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Tarantini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Masiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Capodanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddalena","family":"Lettino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Limbruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Menozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.O. Alfredo","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Saia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Valgimigli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Ageno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Falanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Corcione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Bozzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Parolari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Carone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominick J.","family":"Angiolillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2017.10.051_bib1","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart Disease and Stroke Statistics-2017 Update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.10.051_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4244\/EIJV6I2A31","article-title":"Percutaneous coronary interventions in Europe in 2006","volume":"6","author":"Moschovitis","year":"2010","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2017.10.051_bib3","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1016\/j.jacc.2007.02.046","article-title":"Perioperative management of patients with coronary stents","volume":"49","author":"Brilakis","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.10.051_bib4","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1161\/CIRCULATIONAHA.113.003675","article-title":"Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery","volume":"128","author":"Capodanno","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.10.051_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1378\/chest.08-0675","article-title":"The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)","volume":"133","author":"Douketis","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jcin.2017.10.051_bib6","doi-asserted-by":"crossref","first-page":"e326","DOI":"10.1378\/chest.11-2298","article-title":"Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Douketis","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jcin.2017.10.051_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jacc.2006.10.004","article-title":"Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events","volume":"49","author":"Schouten","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.10.051_bib8","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/hrt.2011.224519","article-title":"Non-cardiac surgery in patients with coronary stents: the RECO study","volume":"97","author":"Albaladejo","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.jcin.2017.10.051_bib9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1160\/TH14-05-0436","article-title":"Perioperative management of oral antiplatelet therapy and clinical outcomes in coronary stent patients undergoing surgery. Results of a multicentre registry","volume":"113","author":"Rossini","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jcin.2017.10.051_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2017.10.051_bib11","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/eurheartj\/ehu282","volume":"35","author":"Kristensen","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2017.10.051_bib12","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.10.051_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4244\/EIJV10I1A8","article-title":"Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: A consensus document from Italian cardiological, surgical and anaesthesiological societies","volume":"10","author":"Rossini","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2017.10.051_bib14","first-page":"E13","article-title":"Antiplatelet therapy and outcome in patients undergoing surgery following coronary stenting: results of the Surgery After Stenting Registry","volume":"89","author":"Rossini","year":"2017","journal-title":"Catheter Cardiovasc Intv"},{"key":"10.1016\/j.jcin.2017.10.051_bib15","first-page":"e156","volume":"134","author":"Bittl","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.10.051_bib16","article-title":"2014 ESC\/EACTS Guidelines on myocardial revascularization","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2017.10.051_bib17","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1111\/j.1538-7836.2007.02694.x","article-title":"Platelet activation, myocardial ischemic events and postoperative non-response to aspirin in patients undergoing major vascular surgery","volume":"5","author":"Rajagopalan","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jcin.2017.10.051_bib18","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.jacc.2017.02.012","article-title":"Use of antiplatelet therapy\/DAPT for post-PCI patients undergoing noncardiac surgery","volume":"69","author":"Banerjee","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.10.051_bib19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCOUTCOMES.115.002155","article-title":"Risk of adverse cardiac and bleeding events following cardiac and noncardiac surgery in patients with coronary stent: how important is the interplay between stent type and time from stenting to surgery?","volume":"9","author":"Saia","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jcin.2017.10.051_bib20","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(15)01039-9","article-title":"1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis","volume":"387","author":"Stone","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2017.10.051_bib21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jcin.2016.12.279","article-title":"Antiplatelet therapy after implantation of bioresorbable vascular scaffolds: a review of the published data, practical recommendations, and future directions","volume":"10","author":"Capodanno","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2017.10.051_bib22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jamcollsurg.2011.12.011","article-title":"The incidence and timing of non cardiac surgery after cardiac stent implantation","volume":"214","author":"Hawn","year":"2012","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.jcin.2017.10.051_bib23","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.jacc.2016.09.967","article-title":"Risk associated with surgery within 12 months after coronary drug-eluting stent implantation","volume":"68","author":"Egholm","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.10.051_bib24","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jacc.2015.11.063","article-title":"Perioperative cardiovascular risk of prior coronary stent implantation among patients undergoing noncardiac surgery","volume":"67","author":"Mahmoud","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.10.051_bib25","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/S0140-6736(13)61720-1","article-title":"Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study","volume":"382","author":"Mehran","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jcin.2017.10.051_bib26","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/ALN.0b013e318186ddf8","article-title":"Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention","volume":"109","author":"Nuttall","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jcin.2017.10.051_bib27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0735-1097(03)00622-3","article-title":"Clinical outcome of patients undergoing non-cardiac surgery in the 2 months following coronary stenting","volume":"42","author":"Wilson","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.10.051_bib28","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0735-1097(00)00521-0","article-title":"Catastrophic outcomes of noncardiac surgery soon after coronary stenting","volume":"35","author":"Kaluza","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.10.051_bib29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/CIRCINTERVENTIONS.109.934703","article-title":"Previous coronary stent implantation and cardiac events in patients undergoing noncardiac surgery","volume":"3","author":"Cruden","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2017.10.051_bib30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCINTERVENTIONS.111.963728","article-title":"Incidence and outcome of surgical procedures after coronary bare-metal and drug-eluting stent implantation: a report from the CREDO-Kyoto PCI\/CABG registry cohort-2","volume":"5","author":"Tokushige","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2017.10.051_bib31","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jacc.2010.07.016","article-title":"Stent thrombosis","volume":"56","author":"Holmes","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.10.051_bib32","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","article-title":"Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents","volume":"293","author":"Iakovou","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2017.10.051_bib33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1161\/CIRCULATIONAHA.106.686048","article-title":"Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment","volume":"116","author":"Airoldi","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.10.051_bib34","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.jacc.2016.07.760","article-title":"Efficacy and safety of dual antiplatelet therapy after complex PCI","volume":"68","author":"Giustino","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.10.051_bib35","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2017.10.051_bib36","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/SLA.0000000000001246","article-title":"The incremental risk of coronary stents on postoperative adverse events: a matched cohort study","volume":"263","author":"Holcomb","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/j.jcin.2017.10.051_bib37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/CIRCINTERVENTIONS.109.914051","article-title":"A\u00a0new tool for the risk stratification of patients with complex coronary artery disease: the Clinical SYNTAX Score","volume":"3","author":"Garg","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2017.10.051_bib38","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/j.jcin.2016.09.044","article-title":"Incidence, characteristics, predictors, and outcomes of repeat revascularization after percutaneous coronary intervention and coronary artery bypass grafting: the SYNTAX trial at 5 years","volume":"9","author":"Parasca","year":"2016","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2017.10.051_bib39","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.jacc.2012.03.010","article-title":"Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score","volume":"59","author":"G\u00e9n\u00e9reux","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2017.10.051_bib40","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0025-6196(12)60271-7","article-title":"Outcome of non cardiac operations in patients with severe coronary-artery disease successfully treated pre-operatively with coronary angioplasty","volume":"67","author":"Huber","year":"1992","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jcin.2017.10.051_bib41","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/CIRCULATIONAHA.112.102715","article-title":"Risk of elective major non cardiac surgery after coronary stent insertion: a population-based study","volume":"126","author":"Wijeysundera","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.10.051_bib42","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1001\/jama.2013.278787","article-title":"Risk of major adverse cardiac events following non cardiac surgery in patients with coronary stents","volume":"310","author":"Hawn","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2017.10.051_bib43","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1586\/14779072.2013.837701","article-title":"Cangrelor: a review on pharmacology and clinical trial development","volume":"11","author":"Franchi","year":"2013","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.jcin.2017.10.051_bib44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11239-012-0737-3","article-title":"Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials","volume":"34","author":"Angiolillo","year":"2012","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jcin.2017.10.051_bib45","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","article-title":"Effect of platelet inhibition with cangrelor during PCI on ischemic events","volume":"368","author":"Bhatt","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2017.10.051_bib46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2011.2002","article-title":"Bridging antiplatelet therapy with cangrelor un patients undergoing cardiac surgery. A randomized control trial","volume":"307","author":"Angiolillo","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.jcin.2017.10.051_bib47","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1161\/CIRCULATIONAHA.117.031164","article-title":"International expert consensus on switching platelet P2Y12 receptor-inhibiting therapies","volume":"136","author":"Angiolillo","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.10.051_bib48","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/j.1538-7836.2011.04456.x","article-title":"Management of patients with recently implanted coronary stents on dual antiplatelet therapy who need to undergo major surgery","volume":"9","author":"Savonitto","year":"2011","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jcin.2017.10.051_bib49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1592\/phco.30.4.420","article-title":"Prolonged infusion of eptifibatide as bridge therapy between bare-metal stent insertion and cardiovascular surgery: case report and review of the literature","volume":"30","author":"Pickett","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jcin.2017.10.051_bib50","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJMoa1401105","article-title":"Aspirin in patients undergoing noncardiac surgery","volume":"370","author":"Devereaux","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2017.10.051_bib51","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7326\/M17-2341","article-title":"Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery","volume":"168","author":"Graham","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jcin.2017.10.051_bib52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/eurheartj\/ehv381","article-title":"Coronary artery bypass grafting-related bleeding complications in patients treated with ticagrelor or clopidogrel: a nationwide study","volume":"37","author":"Hansson","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2017.10.051_bib53","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/jamacardio.2016.3028","article-title":"Safety of preoperative use of ticagrelor with or without aspirin compared with aspirin alone in patients with acute coronary syndromes undergoing coronary artery bypass grafting","volume":"1","author":"Gherli","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcin.2017.10.051_bib54","article-title":"Efficacy and safety of vorapaxar in non-ST-segment elevation acute coronary syndrome patients undergoing noncardiac surgery","volume":"4","author":"van Diepen","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jcin.2017.10.051_bib55","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2017.10.051_bib56","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/europace\/euv309","article-title":"Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation","volume":"17","author":"Heidbuchel","year":"2015","journal-title":"Europace"},{"key":"10.1016\/j.jcin.2017.10.051_bib57","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood-2011-10-378950","article-title":"How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch","volume":"119","author":"Schulman","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jcin.2017.10.051_bib58","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal - full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2017.10.051_bib59","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1093\/eurheartj\/ehu298","volume":"35","author":"Lip","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2017.10.051_bib60","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","article-title":"Perioperative bridging anticoagulation in patients with atrial fibrillation","volume":"373","author":"Douketis","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2017.10.051_bib61","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1185\/030079906X104858","article-title":"Periprocedural bridging therapy in patients receiving chronic oral anticoagulation therapy","volume":"22","author":"Spyropoulos","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jcin.2017.10.051_bib62","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.acvd.2011.09.001","article-title":"Recommendations of the Working Group on Perioperative Haemostasis and the French Study Group on Thrombosis and Haemostasis","volume":"104","author":"Si\u00e9","year":"2011","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.jcin.2017.10.051_bib63","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.hoc.2016.05.005","article-title":"Perioperative management of the direct oral anticoagulants: a case-based review","volume":"30","author":"Bell","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jcin.2017.10.051_bib64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa1112277","article-title":"Rivaroxaban in patients with a recent acute coronary syndrome","volume":"366","author":"Mega","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2017.10.051_bib65","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/CIRCULATIONAHA.111.090464","article-title":"Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) randomized trial","volume":"126","author":"Healey","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2017.10.051_bib66","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11239-015-1167-9","article-title":"Managing target-specific oral anticoagulant associated bleeding including an update on pharmacological reversal agents","volume":"39","author":"Siegal","year":"2015","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jcin.2017.10.051_bib67","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMoa1607887","article-title":"Andexanet\u00a0alfa for acute major bleeding associated with factor Xa inhibitors","volume":"375","author":"Connoly","year":"2016","journal-title":"N\u00a0Engl Med"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879817325177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879817325177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:07:02Z","timestamp":1761847622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879817325177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S1936879817325177"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2017.10.051","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Multidisciplinary Approach on the\u00a0Perioperative Antithrombotic Management\u00a0of Patients With Coronary\u00a0Stents Undergoing Surgery","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2017.10.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}